COSYN (COSYN) Fair Value & Analysis
IN · Market cap ₹149M
Fair value as of: Jul 5, 2026
From 12 valuation models · updated today
Share price −3.9% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹19.21 – ₹28.42 · fair‑value band ₹1.90 – ₹3.73 · the ₹19.89 price screens above the ₹2.98 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
COSYN (COSYN) currently trades at ₹19.89, while our model-based Fair Value estimate is ₹2.98 — implying the stock looks roughly 85.0% overvalued today. We read business quality at 45/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Over the trailing twelve months, COSYN generated revenue of ₹140M at a net margin of 1.1%. Revenue declined 35.5% year over year. It earns a return on equity of 0.6%. Net debt stands at ₹39.5M. Fundamentals as of Jul 5, 2026
Our scenario range runs from ₹1.90 (bear case) to ₹3.73 (bull case); at ₹19.89, the current price sits above that range. The share trades about 33% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
COSYN reported revenue of ₹109M in FY2025 versus ₹135M in FY2021, a compound −5.2%/yr. Reported net income was ₹1.1M in FY2025.
Is COSYN fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is COSYN (COSYN) undervalued?
What is the fair value of COSYN?
What is the quality score of COSYN?
What is the revenue of COSYN (COSYN)?
What is the net profit margin of COSYN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.